Investment
Led En Carta Diagnostics' €5M seed round for at-home molecular diagnostics (Lyme disease, STIs).
En Carta Diagnostics
JUL 10, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
En Carta Diagnostics
Blue Forest Ventures Fund I launch